Business Bites: Esperite makes bioinformatics buy; Whole You back on acquisition trail
This article was originally published in Clinica
Executive Summary
M&A activity in the medtech space continues to gather momentum with Esperite becoming the latest company to invest in bioinformatics, buying US start-up InKaryo. Additionally, Whole You, a subsidiary of Japanese chemical company Mitsui Chemicals, has made its fourth acquisition since it was founded in November 2014, purchasing Respire Medical. Respire is focused on technology to treat obstructive sleep apnea and snoring.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.